Cardiff, United Kingdom

Paul Slater


 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Slater - Innovator in Biological Sample Collection

Introduction

Paul Slater is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of biological sample collection, holding a total of 2 patents. His work focuses on innovative solutions that enhance the efficiency and effectiveness of biological sample handling.

Latest Patents

Among his latest patents is the Biological Sample Collection Card. This invention includes a biological sample receiver that comprises a planar substrate designed for receiving a biological sample. The receiver features an envelope that substantially surrounds the substrate, with an opening to facilitate the deposit of a biological sample onto the surface area. Additionally, a protective cover is formed around the envelope, allowing for the slidable separation of the envelope from the cover. This device is characterized by the unique design where the envelope and cover are formed from a single sheet of folded material.

Career Highlights

Throughout his career, Paul Slater has worked with prominent companies in the healthcare and biotechnology sectors. Notable organizations include GE Healthcare UK Limited and Qiagen Healthcare Biotechnologies Systems GmbH. His experience in these companies has contributed to his expertise in developing innovative solutions for biological sample collection.

Collaborations

Paul has collaborated with several professionals in his field, including Cheryl Louise Potts and Neil John Williams. These collaborations have further enriched his work and contributed to the advancement of his inventions.

Conclusion

Paul Slater is a distinguished inventor whose work in biological sample collection has led to innovative patents that enhance the efficiency of sample handling. His contributions to the field are significant and continue to impact the healthcare and biotechnology industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…